Which AI Will Impact Us the Most

​Everyone is asking the same question right now: Which startups are actually going to impact us the most?


In this conversation, we explore the rise of AI startups that could transform drug discovery, biology, and the future of medicine. We’ll take a deep look at the current market trends and real life experiences.


Special guest: 
Our guest is Gary A. Fowler, CEO of GSD Venture Studios, a Silicon Valley venture studio building AI companies globally. Fowler is a serial entrepreneur and investor who has built 17 companies, including several unicorns and a Nasdaq-listed company. 


He was part of the leadership team at ClickSoftware, which was later acquired by Salesforce for $1.35B. With 25+ years in AI and technology, Gary regularly speaks at global forums including the United Nations, World AI Summit, and Startup World Cup, and writes about AI and innovation for Forbes.


We’ll discuss:



• Which AI categories may create lasting companies

• The rise of scientific AI and AI research assistants

• How AI is transforming biotech and longevity

• Where investors see the next durable AI startups


Opportunity for startup founders:
Pitch your startup in BioTech and receive feedback from Gary. Become part of a meaningful discussion and present the value of your company to investors in the room.